TickerLeague

Total Assets for Moderna (MRNA)

According to Moderna's latest reported financial statements, the company's latest reported total assets is $12.34B USD. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and net assets for the capital-structure picture.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$12.34B

YoY change

-12.8%

5Y CAGR

+11.0%

Peak year (2022)

$25.86B

Latest annual

$12.34B

Total Assets history chart for Moderna (MRNA) from 2016 to 2025

Total Assets history table for Moderna (MRNA) from 2016 to 2025

Fiscal yearPeriod endedReportedTotal AssetsYoY
2025$12.34B-12.8%
2024$14.14B-23.2%
2023$18.43B-28.7%
2022$25.86B+4.8%
2021$24.67B+236.2%
2020$7.34B+361.6%
2019$1.59B-19.0%
2018$1.96B+80.9%
2017$1.08B-23.5%
2016$1.42B

Total Assets values are taken from Moderna's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

The 2025 reading of Moderna (MRNA) total assets is $12.34B – declined 12.8% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Moderna total assets compounded at +11.0% per year, with the latest reading among the more recent periods of the dataset.

Between 2022 and 2025, Moderna total assets plunged 52.3%, falling from $25.86B to $12.34B.

The highest annual total assets of $25.86B was reported in 2022. The lowest in the available history was $1.08B in 2017.

Moderna (MRNA) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $135.41B.

Moderna Total Assets by Year

Moderna Total Assets 2025: $12.34B

Moderna total assets in 2025 was $12.34B, declined 12.8% below 2024.

Moderna Total Assets 2024: $14.14B

Moderna total assets in 2024 was $14.14B, declined 23.2% below 2023.

Moderna Total Assets 2023: $18.43B

Moderna total assets in 2023 was $18.43B, declined 28.7% below 2022.

Moderna Total Assets 2022: $25.86B

Moderna total assets in 2022 was $25.86B, edged up 4.8% from 2021. This figure represents the highest annual value in the available history.

Moderna Total Assets 2021: $24.67B

Moderna total assets in 2021 was $24.67B.

See more financial history for Moderna (MRNA).

Sector peers — Total Assets

Companies in the same sector as Moderna, ranked by their latest total assets.

CompanyTotal AssetsSector
Novo Nordisk A/S (NVO)$542.90BHealthcare
UnitedHealth Group Incorporated (UNH)$309.58BHealthcare
Johnson & Johnson (JNJ)$199.21BHealthcare
Merck & Co., Inc. (MRK)$136.87BHealthcare
AbbVie Inc. (ABBV)$133.96BHealthcare
AstraZeneca PLC (AZN)$114.07BHealthcare
Eli Lilly and Company (LLY)$112.48BHealthcare
Amgen Inc. (AMGN)$90.59BHealthcare

Frequently asked questions

What is Moderna's total assets?

Latest reported total assets for Moderna (MRNA) is $12.34B (period ending December 31, 2025).

How has Moderna total assets changed year-over-year?

Moderna (MRNA) total assets changed -12.8% year-over-year on the latest annual filing.

What is the long-term growth rate of Moderna total assets?

Moderna (MRNA) total assets compound annual growth rate is +11.0% over the most recent 5 years available.

When did Moderna total assets hit its highest annual value?

Moderna total assets reached its highest annual value of $25.86B in 2022.

What was Moderna total assets in 2024?

Moderna (MRNA) total assets in 2024 was $14.14B.

What was Moderna total assets in 2025?

Moderna (MRNA) total assets in 2025 was $12.34B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.